Kymriah to be available via U.K.'s Cancer Drugs Fund for adults with DLBCL

By Shannon Lehnbeuter | Feb 8, 2019 | 8:53 PM GMT

Novartis AG (NYSE:NVS; SIX:NOVN) said Kymriah tisagenlecleucel will be available